Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients.
Raised platelet count, impaired platelet function, and high PCV values are all considered risk factors for the haemorrhagic and/or thrombotic events frequently complicating the course of myeloproliferative disorders. Nevertheless, the outcome in young patients is reported as being frequently uncomplicated and, in these cases, treatment could be deferred. We examined retrospectively the occurrence of haemorrhagic and/or thrombotic events at the onset of myeloproliferative disorders in 108 patients and found that 67.4% of patients, with either raised platelet count or isolated high PCV, were symptomatic at the onset and the rate was similar regardless of disease, sex, age, platelet number and PCV values. We were unable to locate a patient group with a lower rate of complications and, in light of the frequency of symptoms, it seems reasonable to attempt a normalization of blood values in every case.
Grossi
A
A
Department of Haematology, University of Florence, Italy.
Rosseti
S
S
Vannucchi
A M
AM
Rafanelli
D
D
Ferrini
P R
PR
D000328:Adult; D000368:Aged; D005260:Female; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000097:blood / Q000150:complications*; D010976:Platelet Count; D011087:Polycythemia Vera / Q000150:complications; D012189:Retrospective Studies; D013920:Thrombocythemia, Essential / Q000150:complications; D013927:Thrombosis / Q000209:etiology*